Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Advances in Therapy|November 22, 2007
Adverse effects of high-dose interferon-alpha-2a treatment for chronic hepatitis BElif Doyuk Kartal, Saygin Nayman Alpat, Ilhan Ozgunes, et al.
Mikrobiyoloji Bulteni|April 2, 2009
[Analysis of the risk factors in nosocomial urinary tract infections and effect of urinary catheter use on distribution of the causative agents]Nurettin Erben, Saygin Nayman Alpat, Elif Doyuk Kartal, et al.
Influenza Research and Treatment|October 18, 2012
Clinical and Epidemiologic Characteristics of Hospitalized Patients with 2009 H1N1 Influenza InfectionSaygin Nayman Alpat, Gaye Usluer, Ilhan Ozgunes, et al.
Mikrobiyoloji Bulteni|October 3, 2009
[Is pneumatic sample transport system also a carrier for microorganisms?]Saygin Nayman Alpat, Ilhan Ozgüneş, Aşkin Derya Aybey, et al.
Northern Clinics of Istanbul|January 7, 2017
Comparison of adefovir dipivoxil and pegylated interferon alpha-2a treatment in chronic hepatitis B patientsPinar Korkmaz, Gaye Usluer, Ilhan Ozgunes, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 12, 2019
A novel id-iri score: development and internal validation of the multivariable community acquired sepsis clinical risk prediction modelHusrev Diktas, Serhat Uysal, Hakan Erdem, et al.
Antimicrobial Agents and Chemotherapy|December 14, 2011
Efficacy and tolerability of antibiotic combinations in neurobrucellosis: results of the Istanbul studyHakan Erdem, Aysegül Ulu-Kilic, Selim Kilic, et al.
Annals of Clinical Microbiology and Antimicrobials|December 20, 2011
Assessment of the requisites of microbiology based infectious disease training under the pressure of consultation needsHakan Erdem, Suda Tekin-Koruk, Ibrahim Koruk, et al.
Travel Medicine and Infectious Disease|March 25, 2015
Tuberculous and brucellosis meningitis differential diagnosisHakan Erdem, Seniha Senbayrak, Serap Gencer, et al.
Pageof 1